Thursday, November 30, 2023
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Kim A. Eagle, MD, Endowed Professor of Cardiovascular Medicine
Associate Chief Clinical Officer, Cardiovascular Services
University of Michigan Medical Group
Director, Pulmonary Hypertension Program
Michigan Medicine/University of Michigan
Ann Arbor, Michigan, United States
Professor of Medicine
Consultant Respiratory Physician
National Pulmonary Hypertension Unit
Mater Misericordiae University Hospital
University College Dublin
Dublin, Ireland
Professor
Department of Cardiology, Pulmonology, and Intensive Care Medicine
Center for Molecular Medicine Cologne
Cologne Cardiovascular Research Center
Heart Center at the University of Cologne
Cologne, Germany
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
This activity is intended for an international audience of non-US cardiologists, pulmonologists, and rheumatologists.
The goal of this activity is for learners to be better able to describe important updates related to pulmonary arterial hypertension (PAH) derived from the 2022 European Society of Cardiology/European Respiratory Society (ESC/ERS) guidelines on the diagnosis and treatment of pulmonary hypertension, and their potential clinical implications.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Kim A. Eagle, MD, Endowed Professor of Cardiovascular Medicine
Associate Chief Clinical Officer, Cardiovascular Services
University of Michigan Medical Group
Director, Pulmonary Hypertension Program
Michigan Medicine/University of Michigan
Ann Arbor, Michigan, United States
Professor of Medicine
Consultant Respiratory Physician
National Pulmonary Hypertension Unit
Mater Misericordiae University Hospital
University College Dublin
Dublin, Ireland
Professor
Department of Cardiology, Pulmonology, and Intensive Care Medicine
Center for Molecular Medicine Cologne
Cologne Cardiovascular Research Center
Heart Center at the University of Cologne
Cologne, Germany
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC Released: 10/18/2022
Valid for credit through: 10/18/2023, 11:59 PM EST
processing....
